Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 395
Selected: 0
NCT IDTitle
NCT03970252Nivolumab in Combination With Chemotherapy Pre-Surgery in Treating Patients With Borderline Resectable Pancreatic Cancer
NCT00055926CP-724,714 in Treating Patients With Metastatic Breast Cancer
NCT0373235218F-FDG PET and Osimertinib in Evaluating Glucose Utilization in Patients with EGFR Activated Recurrent Glioblastoma
NCT00020787Vaccine Therapy Plus Chemotherapy in Treating Patients With Metastatic or Locally Recurrent Stomach Cancer or Esophageal Cancer
NCT00024310Paclitaxel, Folic Acid, and Lometrexol in Treating Patients With Locally Advanced or Metastatic Solid Tumors
NCT04205838Anakinra in Preventing Severe Chimeric Antigen Receptor T-Cell Related Encephalopathy Syndrome in Patients With Recurrent or Refractory Large B-cell Lymphoma
NCT02701023Compassionate Use of MitoGel in Upper Tract Urothelial Carcinoma
NCT00509431Erlotinib and Sirolimus in Treating Patients With Recurrent Malignant Glioma
NCT06064682An Organoid-based Functional Precision Medicine Trial in Osteosarcoma
NCT00471887Ticilimumab (CP-675,206) in Treating Patients With Stage IIIC or Stage IV Melanoma
NCT00004132Growth Factor to Prevent Oral Mucositis in Patients With Hematologic Cancer
NCT02296229Stereotactic Body Radiation Therapy in Treating Patients With Localized High-Risk Prostate Cancer
NCT03425461Anti-SEMA4D Monoclonal Antibody VX15/2503 With Nivolumab or Ipilimumab in Treating Patients With Stage III or IV Melanoma
NCT06090916Malnutrition Screening and Dietary Intervention to Improve Nutrition Outcomes in Patients With Unresectable Pancreatic Cancer
NCT00798876Low-Fat Fish Oil Diet for Prostate Cancer Prevention
NCT00335751PET Scan Combined With CT Scan in Evaluating Treatment Response in Patients Undergoing Treatment for Bone Cancer or Soft Tissue Sarcoma
NCT00088946Erlotinib and Green Tea Extract (Polyphenon® E) in Preventing Cancer Recurrence in Former Smokers Who Have Undergone Surgery for Bladder Cancer
NCT00616642Rosiglitazone in Treating Patients With Pituitary Tumors
NCT04945642High Dose-Rate Brachytherapy and Stereotactic Body Radiotherapy for the Treatment of Prostate Adenocarcinoma
NCT00042913Epratuzumab in Treating Patients With Non-Hodgkin's Lymphoma
NCT00006968Pentostatin Followed by Peripheral Stem Cell Transplantation in Treating Patients With Advanced Kidney Cancer
NCT00084747Adjuvant Bortezomib Maintenance Therapy After Autologous Peripheral Stem Cell Transplantation in Treating Patients With Intermediate or Advanced Multiple Myeloma
NCT02881242Trametinib in Treating Patients With Progressive Metastatic Hormone-Resistant Prostate Cancer
NCT06980077Ivonescimab for the Treatment of Thymic Cancer
NCT03582475Pembrolizumab With Combination Chemotherapy in Treating Participants With Locally Advanced or Metastatic Small Cell/Neuroendocrine Cancers of Urothelium or Prostate
NCT07229339Zipalertinib With Carboplatin and Pemetrexed for the Treatment of Resectable, Stage II-IIIB, Non-Small Cell Lung Cancer
NCT00003409Motexafin Gadolinium Plus Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
NCT02866994Project Connect Online: An Internet-based Intervention for Women With Breast Cancer
NCT00004865Cetuximab Plus Cisplatin in Treating Patients With Metastatic or Recurrent Cancer of the Head and Neck That Has Not Responded to Cisplatin Chemotherapy
NCT04069923OsteoCrete in Filling Bone Voids in Participants With Bone Voids or Defects
NCT03596710Image-Guided Biopsies in Identifying Mechanisms of Resistance in Participants With Metastatic Castration Resistant Prostate Cancer Undergoing Radioligand Therapy
NCT01859689Internal Radiation Therapy in Treating Patients With Low-Risk Prostate Cancer
NCT02681328Randomized Trial Comparing Performance of Molecular Markers for Indeterminate Thyroid Nodules
NCT02672033Accelerated Hypofractionated Radiation Therapy Immediately Before Surgery in Treating Patients With Malignant Pleural Mesothelioma
NCT07339085Advanced Magnetic Resonance Imaging for the Identification of Recurrent Brain Tumors and Radiation Necrosis
NCT03503643Hemi-Gland Cryoablation for Prostate Cancer at UCLA
NCT01813877Response Monitoring Trial in Patients With Suspected Recurrence of Glioblastoma
NCT01005472Temozolomide and Sunitinib Malate in Treating Patients With Stage III or Stage IV Malignant Melanoma
NCT05978128Utilizing Advocates and Supporters to Increase Lung Cancer Screening Rates in Eligible Participants
NCT04069910Stereotactic Radiation Therapy Before Surgery for the Treatment of Resectable Brain Metastases
NCT0405021568GA-PSMA-11 PET/CT Scan in Impacting Treatment Strategies for Patients With Prostate Cancer
NCT0010099717-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia That Did Not Respond to Imatinib Mesylate
NCT02597894Targeted Biopsies in Determining Response in Patients With Prostate Cancer Undergoing High-Dose-Rate Brachytherapy
NCT02756130Birinapant and Carboplatin in Treating Patients and Targeting Recurrent High Grade Ovarian, Fallopian Tube, or Primary Peritoneal Cancer (HGSOC)
NCT07077239Prostate Cancer Postoperative Stereotactic Body Radiotherapy With Adaptive Technology for Minimizing Toxicity
NCT00107185Vaccine Therapy in Treating Young Patients Who Are Undergoing Surgery for Malignant Glioma
NCT00020852Cryosurgery in Treating Women With Breast Lesions
NCT0336854768Ga-PSMA-11 PET/CT in Imaging Patients With Intermediate or High Risk Prostate Cancer Before Surgery
NCT00761124Informed Decision-Making Regarding Prostate Specific Antigen (PSA) Screening in 50-70 Year Old Latino Men
NCT0492882068Ga-PSMA-11 PET/CT for the Diagnosis of Bone Metastases in Patients With Prostate Cancer and Biochemical Progression During Androgen Deprivation Therapy